Reforms in China Affect IVD Companies’ Q3 2025 Earnings

By Mark Terry | From the Volume XXXII, No. 16 – November 17, 2025 Issue

Most of the in vitro diagnostics (IVD) manufacturers that serve clinical laboratories worldwide reported facing financial “headwinds” in the China IVD market that affected their third-quarter performance. This was due to policy changes in the country…

Read More

---

Global IVD Companies Issue Third Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 16 – November 25, 2024 Issue

HERE IS A SUMMARY OF THE THIRD QUARTER FINANCIAL PERFORMANCE of t…

Read More

---

Global IVD Companies Report First Quarter 2024 Earnings

By Robert Michel | From the Volume XXXI, No. 9 – July 1, 2024 Issue

IN THEIR INITIAL FINANCIAL REPORTING F…

Read More

---

Top Public IVD Companies Report Q3/Q4 2022 Earnings

By Robert Michel | From the Volume XXIX, No. 17 – December 12, 2022 Issue

IT WAS A MIXED BAG OF THIRD QUARTER FINANCIAL RESULTS for the nation’s largest in vitro diagnostics (IVD) manufacturers, with COVID-19 testing volume a contributing factor.  Fluctuating demand for SARS-CoV-2 testing proved perplexing, as some IV…

Read More

---

IVD Firms Grow During 2022, but COVID-19 Revenue Dropped

By Robert Michel | From the Volume XXIX, No. 7 – May 16, 2022 Issue

MOST MAJOR IN VITRO DIAGNOSTICS (IVD) MANUFACTURERS started strong in 2022 as their base businesses regained steam and made up for the significant falloff in COVID-19 diagnostic test revenue.  During first quarter 2022 earnings calls with invest…

Read More

---

IVD Companies Report Record Sales as 2021 Draws to Close

By Robert Michel | From the Volume XXVIII, No. 17 – December 20, 2021 Issue

JUDGING BY THE THIRD QUARTER FINANCIAL PERFORMANCE of the major in vitro diagnostics (IVD) manufacturers, the demand for COVID-19 testing continues to generate a substantial stream of revenue.  During their respective conference calls with investo…

Read More

---